Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Afeyan Noubar
Relationship:   Director, 10% Owner
City:   Lexington
State:   MA
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   7,980,025    

Indirect Shares

   111,880,829      
Direct Value   $14,010,630    

Indirect Value

   $98,146,267      
Total Shares   119,860,854      
Total Value   $112,156,897      


Color Kinetics Inc $0 Receptos, Inc. $0 Editas Medicine, Inc. $13,993,824 Seres Therapeutics, Inc. $16,807 Moderna, Inc. $0 Color Kinetics Inc $0 Receptos, Inc. $0 Editas Medicine, Inc. $13,993,824 Seres Therapeutics, Inc. $16,807 Moderna, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    3   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -42.1%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Color Kinetics Inc CLRK Director 2005-10-03 83,062 2005-10-03 12,000    Premium*  
            Agenus Inc AGEN Director 2006-12-14 0 2006-12-14 0    Premium*  
            Helicos Biosciences Corp HLCSQ Director, 10% Owner 2009-09-18 0 2009-09-18 12,192,640    Premium*  
            Receptos, Inc. RCPT 10% Owner 2013-11-18 1,693,551 0    Premium*  
            DNIB Upwind Inc BIND Director, 10% Owner 2013-09-25 0 2013-09-25 1,562,616    Premium*  
            Bg Medicine, Inc. BGMD Director, 10% Owner 2015-12-09 0 2015-12-09 1,286,274    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-02-08 3,964,256 2016-02-08 991,060    Premium*  
            Cartesian Therapeutics, Inc RNAC 10% Owner 2016-06-27 0 2016-06-27 1,651,862    Premium*  
            Kaleido Biosciences, Inc. KLDO 10% Owner 0 2021-02-08 14,907,627    Premium*  
            Transmedics Group, Inc. TMDX 10% Owner 0 2019-10-29 120,595    Premium*  
            Seres Therapeutics, Inc. MCRB 10% Owner 2019-06-18 15,141 2022-07-05 17,617,352    Premium*  
            Moderna, Inc. MRNA 2024-07-31 2,224,015 2024-07-31 4,632,149    Premium*  
            Axcella Health Inc. AXLA 10% Owner 2020-05-18 0 2022-10-13 8,850,296    Premium*  
            Evelo Biosciences Inc EVLO 2020-06-29 0 2023-07-11 4,977,588    Premium*  
            Codiak Biosciences, Inc. CDAK 10% Owner 0 2022-09-15 1,674,869    Premium*  
            Foghorn Therapeutics Inc. FHTX 10% Owner 2020-10-27 0 2020-10-27 1,851,801    Premium*  
            Sigilon Therapeutics, Inc. SGTX 10% Owner 2020-12-08 0 2023-08-11 0    Premium*  
            Sana Biotechnology, Inc. SANA 10% Owner 2021-02-08 0 2023-09-13 581,695    Premium*  
            Rubius Therapeutics, Inc. RUBY Director, 10% Owner 2021-03-19 0 2021-03-19 17,253,519    Premium*  
            Omega Therapeutics, Inc. OMGA Director, 10% Owner 2021-08-03 0 2023-02-27 21,716,886    Premium*  
* Premium Members only  

Records found :    155         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
FHTX Foghorn Therapeutics Inc. 10% Owner   –       –       •   2020-10-27 4 B $16.00 $2,400,000 I/I 150,000 1,851,801 1.5 -
KLDO Kaleido Biosciences, Inc. Director   –       •       •   2019-03-04 4 A $0.00 $0 I/I 11,070,951 1,910,972 0 -
RCPT Receptos, Inc. 10% Owner   –       –       •   2013-05-14 4 B $14.00 $1,499,988 D/D 107,142 1,924,339 2.45 -
MRNA Moderna, Inc.   –       •      –    2024-06-05 4 AS $145.91 $2,268,804 D/D (15,000) 1,946,931 0 -
MRNA Moderna, Inc.   –       •      –    2024-05-29 4 AS $141.01 $2,901,585 D/D (20,000) 1,961,931 0 -
MRNA Moderna, Inc.   –       •      –    2024-05-22 4 AS $142.95 $2,363,556 D/D (15,000) 1,981,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-09-06 4 AS $107.27 $1,614,094 D/D (15,000) 1,982,209 0 -
MRNA Moderna, Inc.   –       •      –    2024-05-15 4 AS $125.53 $1,909,863 D/D (15,000) 1,996,931 0 -
MRNA Moderna, Inc.   –       •      –    2024-05-08 4 AS $120.37 $1,825,220 D/D (15,000) 2,011,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-08-23 4 AS $112.61 $1,732,613 D/D (15,000) 2,012,209 0 -
MRNA Moderna, Inc.   –       •      –    2024-05-01 4 AS $109.70 $1,663,855 D/D (15,000) 2,026,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-08-16 4 AS $95.70 $975,614 D/D (10,000) 2,027,209 0 -
MRNA Moderna, Inc.   –       •      –    2023-08-02 4 AS $110.59 $1,664,876 D/D (15,000) 2,037,209 0 -
MRNA Moderna, Inc.   –       •      –    2024-04-24 4 AS $107.16 $1,624,836 D/D (15,000) 2,041,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-07-26 4 AS $119.61 $1,806,229 D/D (15,000) 2,052,209 0 -
MRNA Moderna, Inc.   –       •      –    2024-04-17 4 AS $103.10 $1,550,703 D/D (15,000) 2,056,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-07-19 4 AS $124.14 $1,882,152 D/D (15,000) 2,067,209 0 -
MRNA Moderna, Inc.   –       •      –    2024-04-10 4 AS $106.59 $1,606,865 D/D (15,000) 2,071,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-07-12 4 AS $124.59 $1,887,081 D/D (15,000) 2,082,209 0 -
MRNA Moderna, Inc.   –       •      –    2024-04-03 4 AS $97.47 $1,525,268 D/D (15,000) 2,086,931 0 -
MRNA Moderna, Inc. Director   –       •      –    2023-07-05 4 AS $123.46 $1,870,933 D/D (15,000) 2,097,209 0 -
MRNA Moderna, Inc.   –       •      –    2024-03-27 4 AS $105.73 $1,635,864 D/D (15,000) 2,101,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-06-28 4 AS $119.84 $1,823,160 D/D (15,000) 2,112,209 0 -
MRNA Moderna, Inc.   –       •      –    2024-03-20 4 AS $101.05 $1,535,820 D/D (15,000) 2,116,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-06-21 4 AS $121.60 $1,829,227 D/D (15,000) 2,127,209 0 -
  155  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us